No Data
SUNHO BIO-B: Interim Report 2024
Shenghe Life Sciences-B (02898) released its interim performance, with a loss of 36.077 million yuan during the period, a year-on-year narrowing of 41.33%.
Shenghe Bio-B (02898) announced its interim performance for the six months ended June 30, 2024. During this period, the group...
SUNHO BIO-B: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024
Shenghe Biotech-B (02898.HK) will hold a board of directors meeting on August 30th to approve the interim performance.
Shenghe Bio-B (02898.HK) announced that the company will hold a board of directors meeting on August 30, 2024 to approve the interim performance of the company and its subsidiaries for the six months ending June 30, 2024, as well as its publication.
SUNHO BIO-B: NOTICE OF BOARD MEETING
Sunho Biologics' Unit Enters Subscription Letters
